Articles by Rachel Lutz - Page 4

Latest Articles

Alemtuzumab Treatment Better Alleviates Disability in Multiple Sclerosis Patients than Interferon Beta 1a
  |  Rachel Lutz
Alemtuzumab was more beneficial to patients with relapsing remitting multiple sclerosis than subcutaneous interferon beta 1a in various measures of preexisting disability.
Scientists Review Efficacy of Off-Label C. difficile Treatments
  |  Rachel Lutz
Many off label therapeutic options currently exist for treating Clostridium difficile (C. difficile) infection, but combinations of these choices can develop into viable, approved treatments, according to a recently published product review.
Researchers Suspect Traces of C. difficile in Manure Compost From Pigs
  |  Rachel Lutz
Traces of Clostridium difficile bacteria are occasionally found in the final products of manure compost and can even transfer C. difficile into the food chain.
Multiple Sclerosis: How to Prevent Gadolinium Build-Up in the Brain
  |  Rachel Lutz
Physicians have long been concerned that patients with multiple sclerosis who get frequent brain scans accumulate deposits of the rare earth used as a contrast agent, gadolinium. German researchers found an alternative agent.
Multiple Sclerosis: Drug Evaluators Seek Comments
  |  Rachel Lutz
The nonprofit, Institute for Clinical and Economic Review, is preparing a set of recommendations on best drugs for multiple sclerosis and is seeking public comment.
Fecal Transplants Considered as Effective as Antibiotic Treatment for C. difficile Infections
  |  Rachel Lutz
According to new research, fecal transplantations were just as effective as the standard Clostridium difficile (C. difficile) treatment, oral vancomycin taper, in patients with recurrent C. difficile infections.
Why T-Cells Sometimes Turn Pathogenic
  |  Rachel Lutz
A signaling mechanism can turn T-cells into destroyers.
Could Ultraviolet Light Technology Treat Multiple Sclerosis?
  |  Rachel Lutz
Cornell scientists said they created a chemical tool that uses ultraviolet light to track inflammation and even control it. Their hope is it might work to treat inflammatory diseases, perhaps even multiple sclerosis.
Hospital Laundry Group Disputes C. difficile Danger
  |  Rachel Lutz
In a letter, the Textile Rental Services Association strongly responded to the article. David F. Goldsmith, MSPH, PhD, wrote that the story on hospital laundry facilities could “misleadingly create false alarms.”

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$